A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus

NCT06988553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight
Type 2 Diabetes

Interventions

DRUG: AZD5004
DRUG: Placebo

Sponsor

Eccogene